Recombinant Human PD-L1 / B7-H1 Protein with C-terminal 6xHis tag

Recombinant Human PD-L1 / B7-H1 Protein with C-terminal 6xHis tag

$369.00$1,376.00

Recombinant Human PD-L1 / B7-H1 Protein with C-terminal 6xHis tag

SKU: RPA-015 Category:

Background

Programmed death-ligand 1 (PD-L1) also known as cluster of differentiation 274 (CD274) or B7 homolog 1 (B7-H1) is a protein that in humans is encoded by the CD274 gene. PD-L1 is a type 1 transmembrane protein that plays a major role in suppressing the adaptive arm of immune systems during particular events such as pregnancy, tissue allografts, autoimmune disease and other disease states such as hepatitis. PD-L1 binds to its receptor, PD-1, found on activated T cells, B cells, and myeloid cells, to modulate activation or inhibition.

PD-L1 binding to PD-1 contributes to ligand-induced TCR down-modulation during antigen presentation to naive T cells, by inducing the up-regulation of the E3 ubiquitin ligase CBL-b.

 

Product Details

SourceHuman 293 cells (HEK293)
Accession #Q9NZQ7-1
SequenceHuman PD-1L (Phe 19 - Arg 238) + 6x His tag (N-terminus to C-terminus)
PurificationAffinity and Size-HPLC
Purity>95% as determined by SDS-PAGE
ActivityMeasured by its binding ability (100 ng) to PD-1 with EC50 =98 ng/ml
Endotoxin Level<0.10 EU per 1 µg of the antibody by the LAL method
FormulationLyophilized from 0.22 μm filtered solution in PBS, pH7.4
ReconstitutionReconstitute at 0.5 mg/ml in sterile 1xPBS
Predicted Molecular Weight28 kDa
ShippingThe product is shipped with polar packs. Upon receipt, store it immediately at -20 to -70°C
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
• 12 months from the date of receipt at -20 to -70°C as supplied.
• 1 month at 2 to 8°C under sterile conditions

 

References

Ceeraz S, Nowak EC, Noelle RJ. B7 family checkpoint regulators in immune regulation and disease. Trends Immunol. 2013, 34(11): 556-563.

Deng L, Liang H, Burnette B, Beckett M, Darga T, Weichselbaum RR, Fu YX. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest. 2014, 124(2): 687-695.

Weight 1 lbs
Dimensions 1 × 1 × 1 in
size

100 µg, 500 µg